Center for Medicine in the Public Interest

From Powerbase
Revision as of 17:12, 21 April 2010 by Claire Robinson (talk | contribs) (Funding and disambiguation)
Jump to: navigation, search

The Center for Medicine in the Public Interest (CMPI) claims to be a ‘nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered.’ It offers ‘the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness. [1] The director of the Stockholm Network (SN), Helen Disney, used to sit on its now defunct advisory board along with representatives from two think tanks who are part of the SN: International Policy Network (Julian Morris) and Centre for New Europe (Stephen Pollard).[2]

Funding and disambiguation

The Center for Medicine in the Public Interest is not to be confused with the Center for Science in the Public Interest (CSPI). The two are completely unrelated, despite their very similar sounding names.

They also have completely different funding policies. CSPI says it does not accept funding from corporations or government; instead it is funded by individual donors, foundation grants, and subscriptions to its newsletter.[3]

CMPI, on the other hand, stated on a 2005 version of its website that it accepted corporate funding:

Its contributors consist primarily of foundations and individuals, with some corporate support, as described in its 2004 annual report.
PRI solicits and accepts donations from corporations in the health care industry. In order to avoid conflicts of interest, PRI staff and external authors adhere to a Code of Practice.[4]

Founders

Publications and Affiliations

Contact

Headquarters:
Address:
308 East 38th Street
Suite 201
New York, New York 10016
Phone:(212) 417-9169
Fax: (212) 417-9170
email: info@cmpi.org
Paris Office
3 rue Primatice
75013 Paris
Phone: + 33 1 43 31 89 25

CMPI Board of Directors

The CMPI Board of Directors is comprised of some of the nation's leaders in academic medical research, clinical practice, health care delivery, patient advocacy, innovation leadership and science reporting. The board will be involved in helping CMPI reaching a broader group of stakeholders in their respective communities and in shaping CMPI programs in the future.

  • Fred Goodwin, M.D. Professor of Psychiatry, The George Washington University Medical Center
  • Steven Sammut Lecturer, Wharton School, the Law School and the School of Engineering and Applied Science of the University of Pennsylvania
  • Michael Weber, M.D.Associate Dean and Professor of Medicine, SUNY Downstate College of Medicine, Brooklyn, New York

CMPI Advisory Board (no longer in existence)

  • William Roper CEO, University of North Carolina Health Care System
  • Samuel C. Silverstein, M.D. John C. Dalton Professor and Chairman, Department of Physiology and Cellular Biophysics, Columbia University Professor of Medicine, College of Physicians and Surgeons, Columbia University
  • Philip Stieg, M.D. Professor and Chairman, Department of Neurological Surgery, Weill Medical College Neurosurgeon-in-Chief, New York-Presbyterian Hospital

Notes

  1. CMPI. CMPI: Mission Statement Accessed 19 April 2010./
  2. Center for Medicine in the Public Interest. SourceWatch:CMPI Accessed 19 April 2010.
  3. CSPI's Funding Sources, CSPI website, acc 21 Apr 2010
  4. About Center for Medicines in the Public Interest, CMPI website, archived version copyrighted 2005, accessed in web archive 21 Apr 2010
  5. Peter Pitts, Michael Tew and Alexandra Preate. 20 September 2005. 21ST CENTURY HEALTH CARE TERRORISM: THE PERILS OF INTERNATIONAL DRUG COUNTERFEITING Accessed 19 April 2010.